PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
	For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Co-codamol - Pain
PAD Profile : Co-codamol - Pain
Keywords : 
                        combination analgesia, compound analgesics, paracetamol and codeine, non-opioid analgesics
                    Brand Names Include : 
                        Kapake, Solpadol, Tylex, Codipar, Feminax, Paracodal, Solpadeine Max, Zapain
                    Traffic Light Status
Status 1 of 3.
Status : 
                    Green (see narrative)
                             Important
                            Formulations : 
                            - Tablets
 
Important Information : 
                        Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended. 
Secondary Care - for A&E / discharge only.
                    Trust Alignment : 
                    Primary Care
                                ASPH
                                RSFT
                                SASH
                                SABP
                                Comments : 
                    
                            No comments returned.
                    
                Documents : 
                    Status 2 of 3.
Status : 
                    Green (see narrative)
                             Important
                            Formulations : 
                            - Capsules
 
Important Information : 
                        Capsules are more costly than tablets in primary care. 
Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended. 
                    Trust Alignment : 
                    Primary Care
                                ASPH
                                RSFT
                                SASH
                                SABP
                                Comments : 
                    
                            No comments returned.
                    
                Documents : 
                    Status 3 of 3.
Status : 
                    Green (see narrative)
                             Important
                            Formulations : 
                            - Effervescent tablets
 
Important Information : 
                        Fixed combinations are less preferable.
Low dose (8/500 co-codamol) not recommended. 
Avoid effervescent formulations (high sodium content and more costly). Reserve for swallowing difficulties or patients with feeding tubes.
Secondary Care - for A&E / discharge only.
                    Trust Alignment : 
                    Primary Care
                                ASPH
                                RSFT
                                SASH
                                SABP
                                Comments : 
                    
                            No comments returned.
                    
                Documents : 
                    Guidelines
The following guidelines are available for this indication.
Other Drugs
- Co-proxamol (Dextropropoxyphene hydrochloride/para
 - Ziconotide acetate
 - Oxycodone
 - Tramadol with paracetamol
 - Oxycodone with naloxone
 - Fentanyl
 - Tramadol hydrochloride
 - Tramadol with Dexketoprofen
 - Paracetamol
 - Codeine phosphate
 - Dihydrocodeine tartrate
 - Buprenorphine
 - Morphine sulfate
 - Pregabalin
 - Gabapentin
 - Cannabis (medicinal)
 - Co-dydramol 10/500
 - Sufentanil
 - Ibuprofen
 - Meptazinol hydrochloride
 - Pethidine hydrochloride
 - Diamorphine hydrochloride
 - Methoxyflurane
 - Alfentanil hydrochloride
 - Co-dydramol 20/500
 - Co-dydramol 30/500
 - Nefopam hydrochloride
 - Papaveretum
 - Aspirin
 - Parecoxib sodium
 - Ketamine
 
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
                            Committee Name
                            Narrative
                        03 May 2017
                                Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
                                Please prescribe these products GENERICALLY, the branded products (Kapake, Solpadol & Tylex) are considered BLACK on the traffic light system.
Please follow the link here for information generic prescribing https://surreyccg.res-systems.net/pad/Guidelines/Detail/5045
Please follow the link here for information about other paracetamol products. https://surreyccg.res-systems.net/pad/Search/DrugConditionProfile/6159
Associated BNF Codes
04. Central Nervous System
                            04.07.01. Non-opioid analgesics and compound preparations